iShares China Large-Cap ETF vs McKesson Corporation — how do they compare? iShares China Large-Cap ETF trades at $35.37, while McKesson Corporation trades at $899.7 (market cap $105.14B). The key difference: McKesson Corporation pays a 0.42% dividend while iShares China Large-Cap ETF pays none, and McKesson Corporation is trading nearer its 52-week high, iShares China Large-Cap ETF nearer its low. Which is the better fit depends on your goals.
| FXI | MCK | |
|---|---|---|
52-Week High | $41.75 | $995.69 |
52-Week Low | $31.59 | $659.01 |
Market Cap | — | $105.14B |
Sector | — | Health |
Enterprise Value | — | $111.67B |
Dividend Yield | — | 0.42% |
Trailing returns across standard periods
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →